NewsRoom Articles - Page 100 of 154 - PsychedelicNewsWire (PNW)

MondayMay 03, 2021 3:00 pm

Scientists Criticize Drug War at Psychedelics Event Hosted by Federal Health Agency

Last week, a federal health agency begun a speaker series that will be focused on reviewing the science behind psilocybin mushrooms and the therapeutic potential they possess. Experts who aired their views at the inaugural event claimed that federal drug regulations undermined the scientific community’s research objectives and weren’t in line with what the voters wanted. The event is being hosted by the National Cancer Institute, under the National Institutes of Health (“NIH”). The institute notes that it has some clinical trials looking into the use of psilocybin as a treatment of cancer-related depression, with others exploring the psychedelic’s potential…

MondayMay 03, 2021 12:57 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Makes Headway into Canadian Cannabis Vape Market with 25,000 Unit Production Run

Production underway for 25,000 vape cartridges using PULL full spectrum oil formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK Company estimates retail sales revenue for this production run will be approximately $750,000 60% of respondents in StatCan’s Canadian 2020 Cannabis Survey that used vaporizer for cannabis in the last 12 months used oil/extracts “Cannabis 2.0,” the colloquial term for legalization of cannabis derivatives in Canada late in 2019, represented the outset of new trends in how people consume cannabis products with the accessibility of goods like drinks and vape products. While some companies have devoted considerable…

FridayApr 30, 2021 2:00 pm

Community-Based Psychedelic Organizations Key to Future Psychedelic Treatment Accessibility

Psychedelics have become a popular topic of discussion and research, with some states, including Oregon, going so far as to legalize psilocybin-assisted therapy, and the Multidisciplinary Association of Psychedelic Studies advancing MDMA-assisted therapy through the FDA as a treatment for post-traumatic stress disorder. However, despite the progress made in learning more about these substances along with the benefits they possess and how they can be used as alternative treatments for various illnesses, the presence of large for-profit companies, which keep obtaining patents that make them the primary option for psychedelic therapies in the near future, keeps growing at a rather…

FridayApr 30, 2021 1:56 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Is ‘One to Watch’

Tryp Therapeutics is a pharmaceutical company with a focus on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways The company currently has two drug candidates in development: TRP-8802 (targeting fibromyalgia, eating disorders and chronic pain conditions); and TRP-1001 (targeting soft tissue sarcomas) Through its PFN(TM) program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that offer increased efficacy and reduced risk of abuse or addiction The company’s management team has decades of experience in the life sciences industry, including the pharmaceutical and biotechnology markets Oncology therapeutics are expected to…

ThursdayApr 29, 2021 2:30 pm

Serial Entrepreneur Starts First Psychedelic Food Truck

Cynthia Cummings, a serial entrepreneur who is constantly redefining herself, is doing it again Cummings, who is always ready for a new adventure, recently set up a food truck in Royal Bay, British Columbia. The food truck has something for everyone, from juicy burgers and greasy fries to healthy wraps. Cummings has more than a decade’s worth of experience in this area, having run hot dog stands and food trucks for the nightclub crowds for more than 15 years in Toronto. She thought of setting up a food truck after observing that many individuals in the West Shore preferred going…

WednesdayApr 28, 2021 3:00 pm

Trial Finds Psilocybin May Work as Effectively as Common Antidepressants

A clinical trial whose results were published last week has found that psilocybin may be used to treat depression. The phase 2 study was the first randomized trial that compared the effectiveness of commonly prescribed antidepressants with therapeutic doses of psilocybin. Its findings were reported in the “New England Journal of Medicine.” The trial was conducted by scientists from the Imperial College London. Despite the reported findings, there is still more that needs to be determined with regard to the use of psychedelics as a treatment for various mental health conditions, as researchers aren’t sure whether the substances, psilocybin included,…

WednesdayApr 28, 2021 11:56 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Retail Business to Bloom This Spring With Production of 50,000 Blister Packs

PULL starts production of roughly 50,000 blister pack gummies using Taste-T LLC’s successful proprietary manufacturing system Global CBD gummies market size estimated to grow at CAGR of 31.9% until 2025 PULL estimates $200,000 in revenue from initial batch, plans to produce three additional non-THC SKUs with varying levels of ultra-high potency CBD Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently announced it started production on roughly 50,000 Pure Chews edible gummy packs to be sold this Spring (https://ibn.fm/aEibn). The news came shortly…

TuesdayApr 27, 2021 2:30 pm

Former Texas Governor Implores Lawmakers to Pass Psychedelics Research Legislation

Former Republican Governor Rick Perry is backing legislation tabled by State Rep. Alex Dominguez, which pushes for psychedelic therapy treatments for veterans living with PTSD. The bill calls for a clinical study on psilocybin, which is the active ingredient found in magic mushrooms, to be conducted. In an interview last week, Perry stated that the measure was an optimistic piece of legislation that legislators have the opportunity to discuss during this session. Various studies have proposed that psilocybin could be an effective and safe treatment for various mental health conditions, such as depression. Perry noted that while he’s known to…

MondayApr 26, 2021 2:30 pm

Research Finds Previous Use of Antidepressants May Reduce MDMA Effectiveness Against PTSD

A study conducted recently proposes that psychedelic-assisted therapy using MDMA to help treat PTSD is not as efficacious among individuals who have recently used psychiatric drugs commonly prescribed by doctors, known as selective serotonin re-uptake inhibitors. The research findings were reported in the “Psychopharmacology” journal. Allison Feduccia, director of education platform Psychedelic Support and author of the study, explained that antidepressants, in particular SSRIs and MDMA, bound themselves to the same receptors in an individual’s brain. She noted that if an individual used selective serotonin reuptake inhibitors and MDMA concurrently, the effects of the psychedelic would be decreased. Feduccia added…

FridayApr 23, 2021 2:00 pm

New Study Suggests That Psilocybin Could Boost Neuroplasticity

Researchers from the University of Copenhagen in Denmark suggest that psilocybin, which is the main active ingredient found in magic mushrooms, may give rise to speedy and lasting antidepressant effects because it increases neuroplasticity in the brain. The study, which was reported in the “International Journal of Molecular Sciences,” has discovered evidence that psilocybin grows the number of neural connections in the hippocampus and prefrontal cortex of pig brains. Psilocybin has been shown to possess long-lasting and profound effects on mood and personality. However, the mechanisms behind these effects are still not clear. For their study, the scientists from Copenhagen…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000